Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparisons of Nicotinamide Adenine Dinucleotide (NAD) Precursors for Neuroenhancement in Glaucoma Patients

NCT06991712 is registered in ClinicalTrials.gov with Christopher Kai Shun Leung as lead sponsor.

NCT NCT06991712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06991712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparisons of Nicotinamide Adenine Dinucleotide (NAD) Precursors for Neuroenhancement in Glaucoma Patients
Lead sponsor
Christopher Kai Shun Leung
Phase
Phase 2
Overall status
Recruiting
Start date
May 19, 2025
Completion date
December 31, 2026
Enrollment
138 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma